MEMüzeyyen Eryılmaz

Müzeyyen Eryılmaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Müzeyyen Eryılmaz has a total of 143 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Relationship Between Smoking Status and C-Peptide Levels in Patients with Type 2 Diabetes Mellitus

    by Müzeyyen Eryılmaz, İlkay Keskinel, Arman Özer, Kadir Yılmaz

    Background/Objectives: This study aimed to investigate the relationship between smoking status and C-Peptide levels in patients with Type 2 Diabetes Mellitus (T2DM). Methods: The study included patients over the age of 18 with type 2 diabetes mellitus, without any malignancy, who presented to our hospital’s Internal Medicine Outpatient Clinic between January 2022 and April 2023. A total of 204 patients were recruited and examined in three groups: nonsmokers (n = 142), current smokers (n = 37), and former smokers (n = 25). Results: In the nonsmoker group, fasting c-peptide was significantly correlated with neck circumference (r = 0.202), waist circumference (r = 0.311), hip circumference (r = 0.270), insulin (r = −0.358), HbA1c (r = −0.235) and High Dense lipoprotein (r = −0.192). In the smoker group, fasting c-peptide was significantly correlated with diabetes age (r = −0.466), and sodium glucose cotransporter drugs (SGLT-2 inhibitor) usage (r = −0.335). In former smokers, fasting c-peptide was significantly correlated with SBP (r = −0.441), insulin (r = −0.578) and fasting blood sugar (r = 0.520; p < 0.01). In former smokers, fasting c-peptide (r = 0.522) and postprandial c-peptide (r = 0.505; p < 0.01) were significantly and positively correlated with smoking years. In former smokers, fasting c-peptide (r = −0.411) and postprandial c-peptide (r = −0.552) were significantly and negatively correlated with years since quitting. Multivariate analysis results showed that associations of fasting C-peptide levels with tease dummy (B = −1.176; p < 0.05) and insulin dummy (B = 0.052; p < 0.05) were statistically significant. Postprandial C-peptide was significantly associated with age (B = 0.077; p < 0.01), DM age (B = −0.074; p < 0.05), BMI (B = 0.177; p < 0.01) and insulin dummy (B = −2.910; p < 0.01). Conclusions: In former smokers, smoking years were positively correlated with both fasting and postprandial C-peptide levels in univariate analysis; however, this relationship was attenuated and became non-significant when evaluated within the multivariable regression model.

  • Open Access

    The effect of childhood exposure to secondhand smoke on urinary cotinine and 8 hydroxy-2-deoxyguanosine levels: A cross-sectional study

    by Asuman Akkaya Fırat, İlKay Keskinel, Müzeyyen Eryılmaz, Haluk Kılıç, Şirin Güven

    Introduction: The health consequences of exposure to tobacco smoke during childhood can be more severe than those associated with exposure in adulthood. Exposure to secondhand smoke is also a significant issue for children, who constitute a vulnerable group. While urinary cotinine measurements...

  • Open Access

    Serum diamine oxidase levels in allergic asthma and/or allergic rhinitis

    by Ilkay Keskinel, Muzeyyen Eryilmaz, Asuman Akkaya Firat

    Histamine is a central mediator in immunoglobulin E (IgE)-mediated allergic responses, and diamine oxidase (DAO) contributes to extracellular histamine degradation. Altered histamine metabolism has been proposed as a potential modifier of symptom burden in atopic conditions. However, whether circulating DAO protein concentrations differ in patients with allergic asthma and/or allergic rhinitis remains unclear. This study aimed to compare serum DAO concentrations between patients with allergic asthma and/or allergic rhinitis and healthy controls and to examine their associations with immunological and respiratory parameters. In this cross-sectional study, 141 patients with allergic asthma and/or allergic rhinitis and 78 healthy controls were enrolled between January 1, 2025, and March 1, 2025. Serum DAO protein concentrations were measured using enzyme-linked immunosorbent assay. Additional assessments included total IgE, eosinophil count, eosinophil cationic protein, and spirometric parameters. Statistical analyses comprised group comparisons, Spearman's correlation analysis, and receiver operating characteristic curve analysis. Median serum DAO concentrations were significantly lower in patients with allergic asthma and/or allergic rhinitis than in healthy controls (13.8 U/mL vs 28.2 U/mL; P < .001). DAO levels were not significantly correlated with age, sex, total IgE, eosinophil indices, eosinophil cationic protein, or pulmonary function parameters. Receiver operating characteristic analysis demonstrated good discriminatory performance (area under the curve = 0.84, 95% confidence interval = 0.79–0.89; P < .001). The optimal cut-off value of 22.2 U/mL yielded 80% sensitivity and 87% specificity, although this threshold requires external validation. Circulating DAO protein concentrations were reduced in patients with allergic asthma and/or allergic rhinitis compared with healthy individuals. Given the cross-sectional design and the lack of direct enzymatic activity assessment, the results should be interpreted as hypothesis-generating. Prospective studies are warranted to clarify the clinical relevance of DAO measurement in allergic diseases.

  • Open Access

    Pneumococcal Isolation from Adult Sputum Cultures During the COVID-19 and Post-Pandemic Period: A Retrospective Study

    by Ilkay Keskinel, Muzeyyen Eryilmaz, Serap Diktas Tahtasakal

    Objectives: Streptococcus pneumoniae is a major respiratory pathogen. Reports during the COVID-19 era suggest decreased pneumococcal activity. This study aimed to assess the frequency of S. pneumoniae in adult sputum cultures and its antimicrobial susceptibility in a tertiary care hospital. Materials and Methods: This retrospective laboratory-based study was conducted in a tertiary care hospital in Turkey. Sputum cultures from adult patients between October 1, 2021, and October 1, 2023, were analyzed. Demographic, clinical, and antimicrobial susceptibility data of culture-confirmed cases were obtained from medical records. Results: Among 3,433 sputum cultures, only three (0.087%; 95% CI: 0.018%–0.255%) yielded S. pneumoniae. All patients were male with comorbidities such as cardiovascular disease, COPD, or diabetes. Pneumonia developed during hospitalization for non-infectious conditions. All isolates were susceptible to fluoroquinolones, rifampicin, tetracycline, and ceftriaxone; one showed resistance to macrolides and clindamycin. No multidrug resistance was detected. Conclusion: An extremely low pneumococcal isolation rate was observed during the COVID-19 and post-pandemic period. These findings align with global reports of reduced pneumococcal activity. Continued surveillance is essential to monitor epidemiological trends and resistance patterns.

  • Open Access

    Asthma during pregnancy: how obstetricians regard asthmatic patients’ treatment

    by Ilkay Keskinel, Müzeyyen Eryılmaz

    Asthma is the most common pulmonary condition encountered during pregnancy. Based on our clinical experience as a pulmonologist and an internal medicine specialist, we frequently manage pregnant women with asthma, often without prior referral from an obstetrician. This study aimed to evaluate obstetricians' clinical approaches to asthma management during pregnancy using a structured questionnaire. A 12-item questionnaire was developed and distributed electronically to obstetricians nationwide. Participation was voluntary, and respondents were assured of full anonymity. The survey was administered via e-mail through a secure online platform. Among the participants, 26 (61.9%) were specialists, while 16 (38.1%) held academic titles as associate professors or professors. Regarding consultation practices, 23 obstetricians (54.8%) reported consistently consulting a pulmonologist from the early stages of pregnancy, 10 (23.8%) did so frequently, 8 (19.0%) occasionally, and 1 (2.4%) stated that they never sought consultation. In terms of delivery preferences for asthmatic patients, 32 respondents (76.2%) favored vaginal delivery, while 10 (23.8%) preferred cesarean section. Among those who opted for cesarean delivery, 41 (97.6%) reported a preference for regional anesthesia, and only 1 (2.4%) indicated the use of general anesthesia. Asthmatic pregnant patients should be reassured both by obstetricians and by the pulmonologists or internists involved in their care that the majority of medications used in asthma management are classified as Category B and are generally considered safe during pregnancy. Physicians should remain aware of their dual responsibility, both ethical and legal, when making therapeutic decisions during this sensitive period. This study was registered by the scientific board of Fatih Sultan Mehmet Education and Research Hospital (FSM EAH-KAEK 2023/71).

  • Open Access

    Comparative Diagnostic Utility of Systemic Inflammatory Indices Across Hyperthyroidism Subgroups

    by Müzeyyen Eryılmaz, Arzu Güntürk, Kadir Yılmaz

    Comparative Diagnostic Utility of Systemic Inflammatory Indices Across Hyperthyroidism Subgroups - Cyprus Journal of Medical Sciences

  • Open Access

    The impact of graves’ orbitopathy on anterior segment structures and choroidal parameters

    by Neslihan Sevimli, Müzeyyen Eryılmaz, Muhammed Kaan Azarbaz, Güneş Taydaş

    To evaluate Schlemm’s canal (SC) dimensions and choroidal vascularity in patients with Graves’ orbitopathy (GO+), and to compare the findings with those of patients with Graves’ disease (GD) without orbitopathy (GO-) and healthy controls using optical coherence tomography (OCT); additionally, to investigate the potential impact of these anatomical and vascular changes on intraocular pressure (IOP) elevation and glaucoma susceptibility. This cross-sectional study included 164 participants, categorized into three groups: GO+ (n = 38), GO- (n = 76), and healthy controls (n = 50). All subjects were euthyroid for at least six months. SC length (SCL), SC area (SCA), choroidal vascularity index (CVI), luminal area (LA), stromal area (SA), and total choroidal area (TCA) were assessed. Correlations between SCA, SCL, and CVI measurements and other ocular and systemic parameters were analyzed. Demographic, ocular, and systemic parameters were also compared among groups. There were no significant differences in age, sex, intraocular pressure, central corneal thickness, retinal nerve fiber layer thickness, or optic disc parameters across groups (p > 0.05). Hertel exophthalmometry values were significantly elevated in the GO + group (p < 0.001). Both SCL and SCA were significantly lower in the GO + group compared to the GO- and control groups (p < 0.001). The GO- group showed significantly reduced SC measurements compared to controls (p < 0.001). While CVI did not differ significantly among groups (p = 0.758), pairwise analysis revealed significantly higher LA (p = 0.028) and TCA (p = 0.035) levels in the GO + group compared to the GO- group. A borderline correlation was observed between SCA and CVI (r = 0.150, p = 0.050), and a significant negative correlation was noted between Hertel values and SCA (r = − 0.394, p < 0.001). Changes in SC and choroidal structures in GD may be influenced by both mechanical and systemic factors. While these alterations may contribute to IOP elevation, they do not directly imply increased glaucoma risk but could play a role in its development or progression in susceptible individuals.


  • Open Access

    Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study)

    by Ali Kirik, Hilmi Erdem Sumbul, Nizameddin Koca, Türkan Paşalı Kilit, Sibel Demiral Sezer, Emine Binnetoglu, Eşref Araç, İhsan Solmaz, Hacer Şen, İbrahim Demirci, et al.

    Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence data in Türkiye is limited. We aimed to determine the nationwide prevalence of MASLD and advanced hepatic fibrosis risk in subjects with cardiometabolic risk factors (CMRF). Despite recent international consensus redefining fatty liver disease terminology, no nationwide MASLD study has been reported in Türkiye. Methods: This cross-sectional study included 14,371 adults with ≥1 CMRF from 44 centers across 31 cities. MASLD was diagnosed using liver ultrasonography plus cardiometabolic criteria. Advanced fibrosis risk was assessed by fibrosis-4 (FIB-4) score (≥1.3 for ≤65 years; ≥2.0 for >65 years). Logistic regression was used to identify independent predictors of high FIB-4. Results: A total of 61.4% of participants were women, the mean age was 51.3 ± 14.4 years, and the mean BMI was 31.4 ± 6.0 kg/m2. MASLD prevalence was 75.7% (n = 10,873), rising with the number of CMRFs (56.5% with one factor vs. 83.4% with all). The prevalence of high FIB-4 scores was 12.0% overall, being lower in MASLD patients than non-MASLD patients (11.2% vs. 14.4%, p < 0.001). FIB-4 scores decreased with increasing BMI (28.1% underweight vs. 8.7% class III obesity). Male sex, T2DM, and hypertension independently predicted high FIB-4 scores, while smoking, higher BMI, and MASLD were inversely associated. Conclusions: Three-quarters of Turkish adults with CMRF have MASLD. Standard FIB-4 thresholds may underestimate fibrosis risk in obese and smoking populations, underscoring the need for adjusted cut-offs or alternative tools. This study is the first to provide nationwide MASLD prevalence data in Türkiye.


  • Open Access

    Delayed Hypersensitivity Reaction to Dermal Fillers Following mRNA COVID-19 Vaccination

    by Ilkay Keskinel, Müzeyyen Eryılmaz

    Dear Editor, I wish to bring attention to a potential delayed immune reaction associated with dermal fillers in the context of mRNA COVID-19 vaccines. While severe vaccine reactions remain uncommon, the widespread administration of mRNA vaccines and the prevalent use of dermal fillers necessitate a closer examination of their possible interactions. We recently encountered a 59-year-old female patient who developed persistent facial swelling months after receiving the Pfizer-BioNTech SARS-CoV-2 mRNA vaccine. Notably, the patient had a history of dermal filler injections, predominantly hyaluronic acid, administered three to four years prior. Despite various therapeutic interventions, including antihistamines, corticosteroids, and ACE inhibitors, she experienced recurrent episodes of swelling. Ultrasound assessment revealed the absence of residual filler material, leading us to consider an immune-mediated response potentially triggered by the mRNA vaccine. This case highlights the importance of further research into the interaction between mRNA COVID-19 vaccines and dermal fillers. It suggests that individuals with a history of dermal fillers may be susceptible to delayed inflammatory reactions post-vaccination. Clinicians should be aware of this potential adverse event, particularly when evaluating patients with unexplained facial swelling following vaccination.